DOD Biotech Public Company Limited
DOD Biotech Public Company Limited, together with its subsidiaries, manufactures and distributes dietary supplements in Thailand. It offers dietary supplements for beauty and health in various forms comprising capsules, gels, jellies, powder, shot drinks, soft gels, tablets, probiotics, gummies, and direct-to-mouth. The company also provides food supplements and health drinks. In addition, it off… Read more
DOD Biotech Public Company Limited (DOD) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.016x
Based on the latest financial reports, DOD Biotech Public Company Limited (DOD) has a cash flow conversion efficiency ratio of 0.016x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (฿15.43 Million) by net assets (฿941.11 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
DOD Biotech Public Company Limited - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how DOD Biotech Public Company Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
DOD Biotech Public Company Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of DOD Biotech Public Company Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
China Yurun Food Group Limited
F:C7Y
|
0.016x |
|
Tribeca Resources Corporation
PINK:TRRCF
|
-0.054x |
|
Rigel Resource Acquisition Corp.
OTCGREY:RRACF
|
0.150x |
|
Willbes
KO:008600
|
0.151x |
|
Link Prop Investment AB
ST:LINKAB
|
0.102x |
|
Hwail Pharmaceutical Co.Ltd
KQ:061250
|
0.033x |
|
KRISHIVAL
NSE:KRISHIVAL
|
N/A |
|
Rcm Beteiligungs AG
F:RCMN
|
N/A |
Annual Cash Flow Conversion Efficiency for DOD Biotech Public Company Limited (2015–2024)
The table below shows the annual cash flow conversion efficiency of DOD Biotech Public Company Limited from 2015 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ฿891.91 Million | ฿34.80 Million | 0.039x | +84.86% |
| 2023-12-31 | ฿1.08 Billion | ฿22.80 Million | 0.021x | +114.43% |
| 2022-12-31 | ฿893.63 Million | ฿-130.71 Million | -0.146x | -227.33% |
| 2021-12-31 | ฿1.26 Billion | ฿145.00 Million | 0.115x | -56.20% |
| 2020-12-31 | ฿1.22 Billion | ฿321.28 Million | 0.262x | +859.42% |
| 2019-12-31 | ฿1.24 Billion | ฿-42.77 Million | -0.035x | -163.03% |
| 2018-12-31 | ฿1.18 Billion | ฿64.89 Million | 0.055x | -90.83% |
| 2017-12-31 | ฿262.33 Million | ฿156.73 Million | 0.597x | -7.88% |
| 2016-12-31 | ฿223.72 Million | ฿145.09 Million | 0.649x | +308.49% |
| 2015-12-31 | ฿94.83 Million | ฿-29.50 Million | -0.311x | -- |